BDX
Price
$200.44
Change
+$6.10 (+3.14%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
52.94B
14 days until earnings call
Intraday BUY SELL Signals
KMTS
Price
$28.32
Change
+$1.01 (+3.70%)
Updated
Oct 22 closing price
Capitalization
1.69B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDX vs KMTS

BDX vs KMTS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDX vs. KMTS commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a StrongBuy and KMTS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BDX with price predictions
Oct 22, 2026

Momentum Indicator for BDX turns positive, indicating new upward trend

BDX saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In 57 of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at 55%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BDX just turned positive on October 09, 2026. Looking at past instances where BDX's MACD turned positive, the stock continued to rise in 23 of 46 cases over the following month. The odds of a continued upward trend are 50%.

BDX moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BDX crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +3.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDX advanced for three days, in 133 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.

The Aroon Indicator entered an Uptrend today. In 106 of 218 cases where BDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

BDX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 9 (best 1 - 100 worst), indicating outstanding price growth. BDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.168) is normal, around the industry mean (4.961). P/E Ratio (58.536) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (1.107) is also within normal values, averaging (4.143). BDX has a moderately high Dividend Yield (0.022) as compared to the industry average of (0.005). P/S Ratio (2.290) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 78 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for KMTS with price predictions
Oct 22, 2026

KMTS's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for KMTS moved out of overbought territory on September 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 instances where the indicator moved out of the overbought zone. In 9 of the 9 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 14 of 17 cases where KMTS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

KMTS broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on KMTS as a result. In 26 of 27 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for KMTS just turned positive on October 19, 2026. Looking at past instances where KMTS's MACD turned positive, the stock continued to rise in 17 of 17 cases over the following month. The odds of a continued upward trend are 90%.

KMTS moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KMTS crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +4.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where KMTS advanced for three days, in 86 of 102 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

The Aroon Indicator entered an Uptrend today. In 21 of 34 cases where KMTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. KMTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.586) is normal, around the industry mean (4.961). P/E Ratio (-10.567) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (12.626) is also within normal values, averaging (56.876).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
BDX: Fundamental Ratings
BDX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
9
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDXKMTS
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
42%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
62%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BDX: $194.34 vs. KMTS: $27.31)
Brand notoriety: BDX and KMTS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDX: 64% vs. KMTS: 194%
Market capitalization -- BDX: $52.94B vs. KMTS: $1.69B
BDX [@Pharmaceuticals: Other] is valued at $52.94B. KMTS’s [@Pharmaceuticals: Other] market capitalization is $1.69B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 2 FA rating(s) are green while KMTS’s FA Score has 0 green FA rating(s).

  • BDX’s FA Score: 2 green, 3 red.
  • KMTS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BDX and KMTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 6 TA indicator(s) are bullish while KMTS’s TA Score has 6 bullish TA indicator(s).

  • BDX’s TA Score: 6 bullish, 4 bearish.
  • KMTS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KMTS is a better buy in the short-term than BDX.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а +2.89% price change this week, while KMTS (@Pharmaceuticals: Other) price change was +7.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

Reported Earning Dates

BDX is expected to report earnings on Nov 05, 2026.

KMTS is expected to report earnings on Dec 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
BDX
Daily Signal:
Gain/Loss:
KMTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
+3.13%
COO - BDX
55%
Loosely correlated
+4.54%
TMO - BDX
50%
Loosely correlated
-2.52%
BAX - BDX
49%
Loosely correlated
+3.85%
CNMD - BDX
48%
Loosely correlated
+4.95%
MMSI - BDX
48%
Loosely correlated
+2.78%
More

KMTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KMTS has been loosely correlated with BDX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if KMTS jumps, then BDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMTS
1D Price
Change %
KMTS100%
+3.70%
BDX - KMTS
38%
Loosely correlated
+3.13%
RGEN - KMTS
36%
Loosely correlated
-0.72%
MMSI - KMTS
33%
Loosely correlated
+2.78%
ICUI - KMTS
33%
Poorly correlated
+4.66%
NVST - KMTS
33%
Poorly correlated
+3.36%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVAV117.700.19
+0.16%
AeroVironment
FULC3.68-0.02
-0.54%
Fulcrum Therapeutics
SNOW313.96-8.77
-2.72%
Snowflake
IAUX1.45-0.05
-3.33%
i-80 Gold Corp
GAME2.43-0.09
-3.57%
GameSquare Holdings Inc